Background: Current information on the patterns of medication use in nursing home residents living with dementia is conflicting. Aim: The aim of this study was to investigate medication use and its associations with dementia diagnosis in Australian nursing home residents. Methods: A cross-sectional study of 541 residents from 17 Australian nursing homes was performed. Results: Over 12 months, nursing home residents were prescribed a mean (AESD) of 14.5 AE 6.8 medications each. Approximately 95% of residents were prescribed medications for the nervous system, and 94% were prescribed medications for the alimentary tract and metabolism. After adjustment for potential confounders, those with dementia were less likely to be prescribed medications for the cardiovascular system (odds ratio (OR) 0.45, 95% confidence interval (CI) 0.27-0.77, p = 0.0032) and respiratory system (OR 0.38, 95% CI: 0.25-0.60, p < 0.0001). Further analysis of specific medications showed that residents with dementia were more likely to be prescribed risperidone (OR: 9.38, 95% CI: 4.01-21.94, p < 0.0001), buprenorphine (OR 3.37, 95% CI: 1.78-6.36, p = 0.0002) and trimethoprim (OR 1.78, 95% CI: 1.06-2.97, p = 0.0282), but less likely to be prescribed glyceryl trinitrate (OR 0.42, 95% CI: 0.19-0.94, p = 0.0340) and salbutamol (OR 0.34, 95% CI: 0.2-0.6, p = 0.0002) in addition to other specific medications. Conclusions: Increased awareness of possible undertreatment of cardiovascular and respiratory conditions, and possible overtreatment of urinary tract infection, in those living with dementia in nursing home settings may improve management of this vulnerable population.
INTRODUCTION
The United Nations has estimated that, in 2017, the population aged ≥60 years represents approximately 13% of the world's population and that this population is growing faster than all younger age groups. 1 It is estimated that there are 1.2 billion older adults worldwide who suffer multimorbidity. 2 Multimorbidity is common among older adults in developed nations, with data from 31 million US Medicare claims indicating that 62% of those aged 65-74 years and 81.5% of those aged ≥85 years are living with two or more chronic conditions. 3 In Australia, 74.6% of those aged 65-74 years and 83.2% of those aged ≥75 years have multimorbidity. 4 In the US, people aged ≥65 years comprise approximately 13% of the population, but they consume more than one-third of all prescription medications. 5 Multiple diseases and medication use will inevitably lead to polypharmacy, which is associated with inappropriate drug use, medication errors, poor compliance with medication regimes and adverse drug reactions. 6 Concerningly, studies have shown that up to 50% of nursing home residents use nine or more drugs concurrently, putting this group at high risk of the poor outcomes associated with polypharmacy. 7 Cognitive impairment and dementia have previously been found to be associated with prescription medication use, but the findings are inconsistent. A prospective cohort study conducted by Jyrkka et al. 8 found that excessive polypharmacy was associated with a decline in cognitive capacity. In contrast, a cross-sectional study conducted by Elseviers et al. 9 found a marked decrease in prescriptions, particularly pain-relieving medication, among people living with dementia in Belgian nursing homes, which they highlighted as a potential concern. We have conducted previous analyses within an Australian nursing home residents population that have demonstrated that the prescription of cardiovascular medications is associated with a lower probability of dementia diagnosis, which raised questions about whether this may reflect general deprescribing of medications for residents with dementia. 10 Therefore, we considered it important to investigate the patterns of medication use among nursing home residents more extensively to see whether there was a general trend across medication classes that may indicate likely deprescribing of medications for residents living with dementia. The aim of this study was to investigate the patterns of medications prescribed for nursing home residents in Australia, considering a wide range of medication classes, within a cross-sectional study of 17 nursing home facilities across four Australian states with extensive data collection on medication use. In particular, we examined whether there are differences in the use of different medication classes in association with dementia diagnosis.
METHODS

Study Sample and Design
The study sample is from the Investigating Services Provided in the Residential Environment for Dementia (INSPIRED) study, which is a cross-sectional study designed to determine and compare the quality of life, quality of care, use of healthcare resources and costs of nursing homes that provide alternative models of care for people with cognitive impairment and dementia. Data were collected from 17 not-for-profit nursing homes across four Australian states between January 2015 and February 2016. 11 The inclusion criteria for participants in the INSPIRED study were: (1) being permanent residents of the facility; (2) 
Medication Use Measurement
Medication use data were for prescription and non-prescription medicines, and were obtained from three sources: (1) pharmacy data records from nursing homecontracted pharmacists; (2) facility-based medication charts when pharmacy data could not be obtained; or (3) Pharmaceutical Benefits Scheme (PBS) data, 12 provided by the Australian Government Department of Human Services. When available, pharmacy records were used as the primary data source and then facilitybased medication charts; where these were not available, PBS data were used. For each resident in the study, information regarding medication prescriptions in the previous 12 months was collected, including prescription and supply date. The number of different medications prescribed over the 12-month period was determined, regardless of frequency of use. Medications were grouped according to the Anatomical Therapeutic Chemical (ATC) classification system, which is a standardised system developed by the World Health Organization Collaborating Centre for Drug Statistics Methodology and is used world-wide for the categorisation of drugs according to their active ingredients and the organ system they act upon. 13 The ATC system classifies all medications into 14 main groups (first level): alimentary tract and metabolism (A), blood and bloodforming organs (B), cardiovascular system (C), dermatologicals (D), genito-urinary system and sex hormones (G), systemic hormonal preparations, excluding sex hormones and insulins (H), anti-infectives for systemic use (J), antineoplastic and immunomodulating agents (L), musculoskeletal system (M), nervous system (N), antiparasitic products, insecticides and repellents (P), respiratory system (R), sensory organs (S) and various (V). 13 
Dementia and Comorbidity Measures
A diagnosis of dementia was collected from residential facilities' medical records. According to the Australian Aged Care Act 1997, all nursing homes must keep records of nursing home residents' medical conditions, the treatments they were receiving and the type of care that was being provided under a resident's care plan. Data on comorbidities was determined by participants' disease history as recorded in residential facility medical records.
Statistical Analysis
Mean (AESD) values, frequencies and percentages were used to describe the sample. Chi-squared tests, t-tests and Fisher exact tests were used to compare the means and proportions across dementia diagnosis categories. Logistic regression models were used to test associations between diagnosis of dementia and medications. First, unadjusted logistic regressions were conducted with one predictor variable (dementia yes vs no) and a binary outcome variable that identified whether the resident used the class of medication or not. Then, adjusted logistic regressions controlling for age, gender and unbalanced comorbidities (p < 0.05 for dementia and non-dementia groups) were conducted for each of the 14 first-level ATC medications. Unadjusted and adjusted logistic regressions were also used to further investigate the associations between the top 10 specific medications within each main group and dementia diagnosis. All statistical tests were two-sided and analyses were performed using SAS 9.3 (SAS Institute, Cary, NC, USA).
RESULTS
In all, 1323 residents from the 17 facilities were assessed and 901 were eligible to participate in the study. Of these, 541 consented (24% self-consent, 76% by proxy) to be part of the INSPIRED study. The mean age was 85.5 AE 8.5 years, 74.5% were female and 64.3% had been diagnosed with dementia. The distributions of age, gender and comorbidities according to dementia status are summarised in Table 1 . Those living with dementia were less likely to have comorbidities of airway diseases, angina, back pain, congestive cardiac failure, diabetes mellitus, dysphagia, hypertension, ischaemic heart disease, osteoarthritis, rheumatoid arthritis and stroke, but were more likely to have faecal or urinary incontinence.
Approximately 95% of participants were prescribed medications for the nervous system and approximately 94% of residents were prescribed medications for the alimentary tract and metabolism ( Figure 1a ). The next most common medication classes were those for the cardiovascular system (72.1%), anti-infectives for systemic use (68.9%) and dermatologicals (54.1%). The most frequent comorbidities were osteoarthritis (48.4%), hypertension (47.1%), depression (42.9%), urinary incontinence (39.2%) and faecal incontinence (22.5%; Figure 1b) .
During the previous 12-month period, nursing home residents were prescribed on average 14.5 AE 6.8 different medications. Ninety-eight per cent were prescribed more than five different medications and 71% were prescribed more than 10 different medications over the 12-month period (Figure 2a ). These data do not represent concurrent use of medications. Over 12 months, nursing home residents with dementia were prescribed, on average, three fewer medications than nursing home residents without dementia (16.4 vs 13.4; p < 0.0001). A higher proportion of residents with dementia was prescribed fewer than 15 medications over the 12 months, whereas a higher proportion of residents without dementia was prescribed more than 16 medications (Figure 2b) .
Unadjusted logistic regression models showed that a diagnosis of dementia was associated with a lower probability of being prescribed medications for blood and blood-forming organs, cardiovascular system, genito-urinary system and sex hormones, respiratory system and sensory organs, but a higher probability of being prescribed medications for antiparasitic products, insecticides and repellents ( Figure 3 ). Adjusted logistic regression models controlling for age, gender, airway diseases, angina, back pain, congestive cardiac failure, diabetes mellitus, dysphagia, hypertension, ischaemic heart disease, osteoarthritis, rheumatoid arthritis, stroke, faecal incontinence and urinary incontinence showed that dementia was associated with a lower probability of being prescribed medications for the cardiovascular system (odds ratio (OR) 0.45, 95% confidence interval (CI) 0.27-0.76, p = 0.0031) and respiratory system (OR 0.39, 95% CI: 0.25-0.60, p < 0.0001), but an almost fourfold higher likelihood of being prescribed antiparasitic products, insecticides and repellents (OR 3.97, 95% CI 1.09-14.5, p = 0.0369; Figure 3 ).
Further analysis on the top 10 specific medications within each main ATC group showed that nursing home residents with dementia were ninefold more likely to be prescribed risperidone (OR 9.38, 95% CI: 4.01-21.94, p < 0.0001) and threefold times more likely to be prescribed buprenorphine (OR 3.37, 95% CI: 1.78-6.36, p = 0.0002). Residents with dementia were also more likely to be prescribed macrogol combinations (OR 1.68, 95% CI: 1.11-2.55, p = 0.0137) and trimethoprim (OR 
DISCUSSION
The present study has shown that there are significant differences in the prescription of medications for those with a dementia diagnosis among nursing home residents, following adjustment for differences in comorbidities between those with and without dementia.
Residents with dementia had a lower probability of being prescribed certain medications used for the management of cardiovascular and respiratory disease and an increased probability of the use of some nervous system, anti-infective and antiparasitic medications.
Within the classes of cardiovascular and respiratory disease medications, it is of note that there was significantly reduced use of medications that can be considered as used for symptomatic management (e.g. salbutamol, glyceryl trinitrate) by those diagnosed with dementia, whereas the use of other medications that are not used PRN (e.g. tiotropium, fluticasone, furosemide) did not differ significantly. This is likely to reflect reduced awareness of, or ability to communicate, symptoms by those residents living with dementia.
14 Not surprisingly, residents diagnosed with dementia were more likely to be prescribed medications that are likely to be used for the management of behavioural and psychological symptoms of dementia (BPSD). Those living with dementia were ninefold more likely to be prescribed the antipsychotic risperidone. Globally, clinical practice guidelines recommend avoiding the use of antipsychotics for the management of BPSD wherever possible, due to the increased risk of cerebrovascular adverse events and death. 15 The present study demonstrated that one-quarter of nursing home residents with dementia had been prescribed risperidone, suggesting that this medication is likely to be overprescribed. The high prevalence of use of this medication indicates that it is unlikely that risperidone is being used only for the management of symptoms that place the residents or others at significant risk of harm. These findings are consistent with those of others reporting a high rate of use of antipsychotics in nursing home residents. 16 Buprenorphine is an opioid used for treating pain. In the present study, residents with dementia were threefold more likely to be prescribed buprenorphine than those without dementia. Pain has been reported to be observed more often in residents with severe dementia, and pain severity was significantly correlated with dementia severity. 17 A randomised control trial has demonstrated the efficacy of treating pain in the management of BPSD. 18 In that study, nursing home residents with moderate to severe BPSD were treated with a stepped pain management protocol, including paracetamol, morphine, buprenorphine or pregabalin. Residents with swallowing difficulties received buprenorphine via a transdermal patch. The trial found significant reductions in agitation and the severity of overall neuropsychiatric symptoms. The increased use of buprenorphine observed in the residents with dementia in this study may be due to the management of BPSD. Equally, the increased use of buprenorphine may be due to the ease of administration via a patch. However, it is of note that a significant increase in fentanyl use, which is also administered by patch, was not observed in the present study. There was, in fact, a non-significant reduction in the use of fentanyl as well as oxycodone. Although the present analysis does not indicate whether there is a difference in the total opioid use, it is unlikely that differential prescription of opioids used less frequently explains the increase in buprenorphine use. An increase in the prescription of trimethoprim was also observed in residents with dementia, after adjustment for differences in comorbidities, including urinary incontinence. This antibiotic is commonly used for the treatment of urinary tract infections (UTIs). The reason for this increased use cannot be determined, but it is possible that greater confusion or worsening cognition in residents with dementia is attributed to UTIs, prompting treatment or increased testing for UTIs. Other studies have shown that a high proportion of UTIs in nursing home residents, especially for the residents with advanced dementia, were misdiagnosed. 19 Other differences in medication use between those with and without dementia that were observed in the present study were an increase in the prescription of macrogol combinations for those with dementia. This may possibly be in association with the increased prescription of buprenorphine. In addition, there was decreased use of some dermatologicals in those with dementia, but the reasons for this are unclear.
Nursing home residents with dementia were almost fourfold more likely to be prescribed the antiparasitic products in the present study, although the prevalence of these prescriptions was low. In nursing home settings, these products are mostly used to treat scabies. Scabies has been shown to be strongly associated with nursing home residents with dementia and it is still a challenge in the care of residents with dementia in nursing homes. 20 
Figure 1
Number of residents (a) prescribed Anatomical Therapeutic Chemical (ATC) classes of medications over the previous 12 months and (b) with specific disease histories across the study cohort (n = 541).
Polypharmacy is common among nursing home residents, with the prevalence of polypharmacy in nursing homes varying widely from 15% to more than 90% depending on the definition used. [21] [22] [23] The present study showed that over a 12-month period, each resident was prescribed, on average, 14.5 different medications. This is much higher than most estimates of polypharmacy in other studies, but this figure does not indicate the use of concurrent medications because it reflects total use over a 12-month period.
Common interventions to improve optimal prescribing practices for people living in nursing homes include medication reviews and educational interventions. Medication management reviews for nursing home residents are available in Australia and the need for a review can be identified by the resident, a family member or someone involved in the healthcare of the resident (e.g. staff of the nursing home, general practitioner or pharmacist). 24 A recent systematic review concluded that medication reviews conducted by group. *The reference group was residents without dementia, adjusted for age, gender and unbalanced comorbidities (p < 0.05) among residents with and without dementia. OR, odds ratio; CI, confidence interval.
pharmacists or a multidisciplinary team appear to reduce the number of prescribed medications, the number of potentially inappropriate medications and adverse effects, including hospitalisations and mortality. 25 We have demonstrated that the use of potentially inappropriate medications was associated with quality of life in older adults living in nursing homes with a high prevalence of cognitive impairment and dementia. 26 Awareness by pharmacy and healthcare staff of the medication patterns observed in the present study are important, because people living with dementia may be getting respiratory and cardiovascular symptoms undertreated, in addition to the possible overuse of antipsychotics, which is likely to be associated with poorer quality of life. This interpretation of the findings of the present study are limited by its cross-sectional design, which does not allow examination of the temporal sequence of the observed associations. The data did not allow for analysis based on different subtypes of dementia, which may be associated with different medication uses (in particular for the management of BPSD). The list of comorbidities obtained from the medical records was not restricted to the disease experience of the participants over the previous 12 months, so some conditions may not be current. A significant strength of the present study was the use of dispensing data from individual pharmacy records, which are inclusive of all medications dispensed for the residents while at the facility. Alternative sources of medication data were used where these data were not available. Therefore, data on medications are considered highly accurate. However, the gold standard for measuring medication use is to examine the medication charts of the participants, but this was not feasible in the present study. Using dispensing data from pharmacy records allowed a systematic exploration of the full spectrum of prescription medications and their associations with dementia by ATC classifications.
In summary, in the present study most nursing home residents were prescribed medications for the nervous system and for the alimentary tract and metabolism over a 12-month period. Multiple medication use was common for both dementia and non-dementia residents. Residents with dementia had significantly greater use of medications for the treatment of BPSD (including buprenorphine) and UTIs. In contrast, drugs commonly used for the treatment of symptoms in the respiratory, cardiovascular and gastrointestinal systems were used significantly less frequently in residents with dementia. Medications used for prevention in cardiovascular disease management, such as atorvastatin and metoprolol, were also used less often in residents with dementia. Awareness by pharmacy and healthcare staff of the likely overuse of antipsychotics, potential undertreatment of cardiovascular and respiratory symptoms and possible overtreatment of UTIs in those living with dementia in a nursing home population may improve management and quality of life in this vulnerable population.
Supporting information
Additional supporting information may be found online in the Supporting Information section at the end of the article: Table S1 . Top 10 nervous system medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S2 . Top 10 alimentary tract and metabolism medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S3 . Top 10 blood and blood-forming organ medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S4 . Top 10 cardiovascular system medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S5 . Top 10 dermatological medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S6 . Top 10 genito-urinary system and sex hormone medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S7 . Top 10 systemic hormonal preparations, excluding sex hormones and insulins, prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S8 . Top 10 anti-infective (for systemic use) medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S9 . Top 10 antineoplastic and immunomodulating agent medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S10 . Top 10 musculoskeletal system medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S11 . Antiparasitic products, insecticides and repellent medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S12 . Top 10 respiratory system medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S13 . Top 10 sensory organ medications prescribed during a 1-year period to the 541 residents and their associations with dementia. Table S14 . Various medications prescribed during a 1-year period to the 541 residents and their associations with dementia.
